Undisclosed 20S proteasome activator for parkinson’s disease
/ Booster Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 13, 2025
Booster Therapeutics…announced today it has received a research grant of $5 million dollars from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) as part of MJFF’s Therapeutics Pipeline Program.
(Businesswire)
- "This will support the development of small molecule therapeutics that re-activate the cellular quality control machinery of proteasomes."
Financing • Parkinson's Disease
1 to 1
Of
1
Go to page
1